IDENTIFICATION OF A HIGH-RISK GROUP AMONG PATIENTS WITH ORAL CAVITY SQUAMOUS CELL CARCINOMA AND pt1 2N0 DISEASE
|
|
- Nathaniel Wilcox
- 5 years ago
- Views:
Transcription
1 doi: /j.ijrobp Int. J. Radiation Oncology Biol. Phys., Vol. 82, No. 1, pp , 2012 Copyright Ó 2012 Elsevier Inc. Printed in the USA. All rights reserved /$ - see front matter CLINICAL INVESTIGATION Head and Neck Cancer IDENTIFICATION OF A HIGH-RISK GROUP AMONG PATIENTS WITH ORAL CAVITY SQUAMOUS CELL CARCINOMA AND pt1 2N0 DISEASE CHUN-TA LIAO, M.D.,* y CHIEN-YU LIN, M.D., yz KANG-HSING FAN, M.D.,* z HUNG-MING WANG, M.D.,* x SHU-HANG NG, M.D.,* k LI-YU LEE, M.D., y{ CHUEN HSUEH, M.D., y{ I-HOW CHEN, M.D.,* y SHIANG-FU HUANG, M.D.,* y CHUNG-JAN KANG, M.D.,* y AND TZU-CHEN YEN, M.D, PH.D. y# *Department of Otorhinolaryngology, Head and Neck Surgery, y Department of Head and Neck Oncology Group, x Department of Hema-Oncology, k Department of Diagnostic Radiology, { Department of Pathology, and # Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan; and z Department of Radiation Oncology, Chang Gung Memorial Hospital and Graduate Institute of Clinical Medical Sciences of Chang Gung University, Taoyuan, Taiwan Purpose: In the American Joint Committee on Cancer 2010 classification system, pt1 2N0 oral cavity squamous cell carcinoma (OSCC) is considered an early-stage cancer treatable with surgery alone (National Comprehensive Cancer Network 2010 guidelines). Our aim was to evaluate the feasibility of surgery alone for pt1 2N0 OSCC patients. Methods and Materials: Among 1279 previously untreated OSCC patients referred to our hospital between January 1996 and May 2008, we identified 457 consecutive patients with pt1 2N0 disease. All had radical tumor excision with neck dissection. A total of 387 patients showing pathologic margins greater than 4 mm and treated by surgery alone were included in the final analysis. All were followed up for at least 24 months after surgery or until death. The 5-year rates of control, distant metastasis, and survival were the main outcome measures. Results: The 5-year rates in the entire group of pt1 2N0 patients were as follows: local control, 91%; neck control, 92%; distant metastases, 1%; disease-free survival, 85%; disease-specific survival, 93%; and overall survival, 84%. Multivariate analysis identified poor differentiation and pathologic tumor depth of 4 mm or greater as independent risk factors for neck control, disease-free survival, and disease-specific survival. A scoring system using poor differentiation and tumor depth was formulated to define distinct prognostic groups. The presence of both poorly differentiated tumors and a tumor depth of 4 mm or greater resulted in significantly poorer 5-year neck control (p < ), disease-free (p < ), disease-specific (p < ), and overall survival (p = ) rates. Conclusion: The combination of poor differentiation and pathologic tumor depth of 4 mm or greater identified a subset of pt1 2N0 OSCC patients with poor outcome, who may have clinical benefit from postoperative adjuvant radiotherapy. Ó 2012 Elsevier Inc. Adjuvant radiotherapy, Oral cavity, Squamous cell carcinoma, Survival, Outcome. INTRODUCTION In the American Joint Committee on Cancer 2010 classification system, pt1 2N0 oral cavity squamous cell carcinoma (OSCC) is considered to be an early-stage cancer (p Stage I II) (1). Numerous reports, including the NCCN 2010, do not recommend the use of postoperative adjuvant radiotherapy (RT) in OSCC patients with pt1 2N0 disease (2). We have previously shown that specific pathologic characteristics are important independent adverse prognostic factors in patients with OSCC (3 8). However, the prognostic significance of these factors has not been specifically tested in patients with pt1 2N0 disease. This report expands on previous research by focusing on this patient group. The aim of this study was twofold. The first was to identify potential prognostic factors affecting the outcomes of pt1 2N0 OSCC patients. The second was to determine whether a subgroup of high-risk patients may benefit from more aggressive adjuvant therapies (radiation alone or chemoradiation). We sought to address these issues in 387 consecutive patients with pt1 2N0 disease showing pathologic margins greater than 4 mm and treated by surgery alone between January 1996 and May METHODS AND MATERIALS Patients All work was performed in accordance with the Declaration of Helsinki, and approval was granted by the Institutional Review Reprint requests to: Tzu-Chen Yen, M.D., Ph.D., Department of Nuclear Medicine, Chang Gung Memorial Hospital at Linko, No. 5, Fu-Hsing St., Kwei-Shan, Taoyuan, Taiwan, Republic of China. Tel: , ext. 2673; Fax: ; yen1110@adm.cgmh.org.tw 284 This study was supported by grants CMRPG and CMRPG from Chang Gung Memorial Hospital. Conflict of interest: none. Received June 1, 2010, and in revised form Aug 2, Accepted for publication Sept 8, 2010.
2 High-risk patients and pt1-2n0 OSCC d C.-T. LIAO et al. 285 Board of Chang Gung Memorial Hospital, Taoyuan, Taiwan. The inclusion criteria were as follows: presence of a previously untreated tumor scheduled for radical surgery with neck dissection (ND), histologic diagnosis of OSCC, and presence of pt1 2N0 (pt1 2 tumor status and pn0 status) disease. Because all patients were required to have pn0 disease, cn0 patients who were pn+ were excluded. In contrast, cn+ patients who had pn0 disease were eligible to participate. Additional inclusion criteria were the patient s willingness to undergo computed tomography guided biopsy or surgical exploration if necessary and the absence of other suspected distant metastatic lesions detected by imaging. Exclusion criteria were refusal or inability to receive definitive treatment. Patients with close or positive margins were also excluded. In addition, no patient had received any previous adjuvant therapy. All participants underwent an extensive presurgical evaluation. This included a medical history and complete physical examination, flexible fiberoptic pharyngoscopy, complete blood count and routine blood biochemistry, computed tomography or magnetic resonance imaging scans of the head and neck, chest radiographs, bone scan, and liver ultrasonography. Patient staging was performed according to the 2010 American Joint Committee on Cancer 7th edition staging criteria (1). Surgery The primary tumors were excised with surgical margins of 1 cm or greater (both peripheral and deep margins). Classic radical or modified NDs (Level I V) were performed in patients with clinically positive lymph nodes, whereas supraomohyoid NDs (Level I III) were used in clinically node-negative patients. Patients were treated with bilateral NDs if the primary tumor reached or crossed the midline sagittal plane of the oral cavity. The tumor margins were sent for frozen section. If a margin was positive, additional tissue was excised and sent for frozen section to ensure that the margin was free of tumor. The surgical defects were repaired with primary closure or reconstructed immediately by plastic surgeons using free or local flaps. Determination of optimal cutoff values for pathologic tumor depth The optimal cutoff values for tumor depth were calculated as previously described (7). In brief, different values of tumor depth (from 1 to 15 mm) were tested by use of the Kaplan-Meier method based on the 5-year local control, neck control, distant metastases, disease-free survival (DFS), disease-specific survival (DSS), and overall survival (OS) rates. A cutoff point of 4 mm yielded the highest significance in terms of control and survival rates. Statistical methods Follow-up was continued until May All patients received follow-up examinations for at least 24 months after surgery or until death. Descriptive statistics are summarized as frequencies, percentages, means, medians, ranges, and standard deviations. The survival time and the time intervals to recurrence or distant metastases were calculated from the operation date. The Kaplan-Meier method was applied for outcome analysis of the 5-year local control, neck control, distant metastases, DFS, DSS, and OS rates. Statistical significance was tested by log-rank test. Univariate and multivariate analyses were used to identify the independent predictors of outcome. Multivariate analysis was performed via Cox regression through a forward selection procedure. Two-sided p values < 0.05 were considered statistically significant. RESULTS Patients Among 1279 previously untreated OSCC patients referred to our hospital between January 1996 and May 2008, we identified 548 consecutive patients with pt1 2 disease. Of the 548 pt1 2 patients, 91 were excluded because they did not undergo ND. Of the 457 pt1 2N0 patients, 70 were excluded because of previous adjuvant RT (n = 60) or the presence of close margins (#4 mm) (n = 22). A total of 12 patients had both a history of previous adjuvant RT and close margins. Therefore the final study population included 387 patients (359 men and 28 women; mean age, years; age range, years). In total, 357 patients (92%) received ipsilateral ND whereas the remaining 30 (8%) had bilateral ND. The median follow-up was 66 months (mean, months; range, months). At the time of analyses, 315 patients (81%) were alive and 72 (19%) were dead (27 from primary cancer, 23 from other forms of cancers, and 22 from non-neoplastic causes). In an event-based analysis, 38 patients (10%) had local recurrences, 31 (8%) had neck recurrences, 6 (2%) had distant metastases, and 77 (20%) had second primary tumors. A total of 59 patients (15%) showed local and/or neck recurrences, and salvage therapy was carried out in 53 individuals (90%). Of this patient group, 30 (57%) subjects were alive and 23 (43%) were dead. The 5-year rates were as follows: local control, 91%; neck control, 92%; distant metastases, 1%; DFS, 85%; DSS, 93%; and OS, 84%. The demographic and clinicopathologic characteristics of the study participants are presented in Table 1. Prognostic factors In univariate analyses, poor differentiation was an adverse predictor of 5-year neck control, DFS, and DSS; tumor depth of 4 mm or greater was a significant prognostic factor for neck control, DFS, and OS; perineural invasion was a significant prognostic factor for neck control; and lymphatic invasion was an adverse predictor for OS. Multivariate analysis of 5-year control and survival rates is depicted in Table 2. Poor differentiation of tumor was an independent risk factor for 5-year neck control, DFS, and DSS; tumor depth of 4 mm or greater was an independent adverse prognostic factor for 5-year neck control, DFS, and DSS rates; and lymphatic invasion was an independent adverse predictor for OS. However, only 2 patients showed lymphatic invasion. Table 3 depicts the clinical course of pt1 2N0 patients with poorly differentiated tumors (n = 19). Prognostic scoring system using differentiation and tumor depth A scoring system using poor differentiation and tumor depth was formulated to define distinct prognostic groups: Group 1 (reference category), well/moderate differentiation and tumor depth less than 4 mm (n = 121); Group 2, well/ moderate differentiation and tumor depth of 4 mm or greater
3 Characteristics Table 1. Five-year control and survival rates in pt1 2N0 OSCC patients (n = 387) Local control Neck control Distant metastases Disease-free survival Disease-specific survival Overall survival 5-y %, n event p 5-y %, n event p 5-y %, n event p 5-y %, n event p 5-y %, n event p 5-y %, n event p Age #40 y (89) 95 (7) 93 (7) 4 (3) 89 (12) 94 (7) 86 (14) >40 y (298) 89 (31) 92 (24) 1 (3) 84 (48) 93 (20) 84 (58) Gender Male (359) 90 (37) 92 (30) 1 (6) 85 (58) 93 (25) 85 (65) Female (28) 96 (1) 96 (1) 0 (0) 93 (2) 92 (2) 81 (7) Tumor subsites Tongue (189) 93 (14) 90 (19) 1 (2) 84 (30) 93 (12) 86 (33) Mouth floor (16) 100 (0) 94 (1) 0 (0) 94 (1) 100 (0) 54 (6) Lip (18) 82 (2) 94 (1) 0 (0) 77 (3) 94 (1) 82 (3) Buccal (106) 93 (11) 95 (5) 1 (2) 91 (13) 95 (8) 88 (19) Alveolar ridge (37) 79 (8) 91 (3) 3 (1) 77 (9) 88 (4) 82 (6) Hard palate (4) 50 (1) 75 (1) 0 (0) 38 (2) 75 (1) 75 (1) Retromolar (17) 88 (2) 94 (1) 6 (1) 87 (2) 94 (1) 81 (4) Differentiation Well/moderate (368) 91 (36) 93 (26) 1 (5) 86 (56) 94 (22) 85 (67) Poor (19) 88 (2) 74 (5) 5 (1) 68 (4) 73 (5) 73 (5) pt status pt1 (134) 90 (12) 95 (6) 1 (2) 87 (15) 95 (7) 88 (17) pt2 (253) 91 (26) 90 (25) 2 (4) 84 (45) 93 (20) 82 (55) Tumor depth* <4 mm (128) 90 (10) 97 (4) 1 (1) 89 (11) 96 (4) 88 (17) $4 mm (259) 91 (28) 90 (27) 2 (5) 83 (49) 92 (23) 82 (55) Perineural invasion y No (339) 91 (34) 93 (23) 1 (5) 86 (49) 94 (22) 86 (61) Yes (47) 90 (4) 83 (8) 2 (1) 76 (11) 89 (5) 75 (11) Vascular invasion y No (384) 91 (38) 92 (31) 1 (6) 85 (60) 93 (27) 84 (72) Yes (2) 100 (0) 100 (0) 0 (0) 100 (0) 100 (0) 100 (0) Lymphatic invasion y < No (384) 91 (38) 92 (31) 1 (6) 85 (60) 93 (27) 85 (70) Yes (2) 100 (0) 100 (0) 0 (0) 100 (0) 100 (0) 0 (2) 286 I. J. Radiation Oncology d Biology d Physics Volume 82, Number 1, 2012 Abbreviation: OSCC = oral cavity squamous cell carcinoma. * Best cutoff value of tumor depth. Tumor depth was defined as the measured thickness from the surface of the normal mucosa to the deepest portion of the tumor. y Unavailable data: perineural (n = 1), vascular (n = 1), and lymphatic (n = 1).
4 High-risk patients and pt1-2n0 OSCC d C.-T. LIAO et al. 287 Table 2. Multivariate analysis of 5-year control and survival rates (n = 387) Characteristics Local control Neck control Distant metastasis Disease-free survival Disease-specific survival Overall survival Poor differentiation p NS NS < NS HR (95% CI) ( ) ( ) ( ) Tumor depth $4 mm p NS NS NS HR (95% CI) ( ) ( ) ( ) Lymphatic invasion p NS NS NS NS NS < HR (95% CI) ( ) Abbreviations: NS = not significant; HR = hazard ratio; CI = confidence interval. (n = 247); Group 3, poor differentiation and tumor depth less than 4 mm (n = 7); and Group 4, poor differentiation and tumor depth of 4 mm or greater (n = 12). The local control, neck control, DFS, DSS, and OS rates at 5 years did not differ significantly between Groups 1, 2, and 3. Patients in Group 4 showed significantly poorer 5-year neck control, DFS, DSS, and OS rates compared with other risk categories. Of note, there was a marginally significant difference between Groups 3 and 4 in terms of DSS and OS rates (Fig. 1). DISCUSSION The NCCN 2010 guidelines do not support the use of postoperative adjuvant RT in OSCC patients with pt1 2N0 disease. A subset of these patients, however, may eventually have locoregional or distant recurrence. We hypothesized, on the basis of our clinical observations that subgroups of OSCC patients exist within pt1 2N0 disease whose clinical behavior differs. A survival benefit for postoperative RT would most readily be seen in patients with higher rates of locoregional or distant recurrence. Besides the lymph node status, numerous other pathologic characteristics (tumor depth, close/positive margins, perineural invasion, lymphovascular permeation, tumor differentiation) also act as risk factors (3 10). To our knowledge, no study has specifically addressed whether these clinicopathologic features may predict prognosis in OSCC patients with pt1 2N0 disease (11). Previous research has suggested that poor tumor differentiation is an independent risk factor for neck lymph node Table 3. Clinicopathologic characteristics of pt1 2N0 OSCC patients with poor differentiation (n = 19) Interval between primary surgery and event (mo) No. Age (y) Site Tumor depth (mm) Tumor recurrence Neck recurrence DM Tumor salvage Neck salvage DOD AND 1 45 Tongue Retromolar Tongue Tongue Tongue Tongue Tongue Buccal Tongue Gum 5 8* Buccal Tongue Tongue Lip Tongue Buccal Buccal Tongue Tongue 15 14* + 24 Abbreviations: OSCC = oral cavity squamous cell carcinoma; DM = distant metastasis; DOD = died of disease; AND = alive without disease. * In-field failure at neck region.
5 288 I. J. Radiation Oncology d Biology d Physics Volume 82, Number 1, 2012 Fig. 1. Subgroup analysis of 5-year local control rates (a), neck control rates (b), distant metastasis rates (c), disease-free survival rates (d), disease-specific survival rates (e), and overall survival rates (f) according to presence of poor differentiation and tumor depth of 4 mm or greater. metastasis and clinical outcomes in OSCC patients (12 20). However, disease status varied widely among participants enrolled in previous studies. The prognostic importance of depth of tumor invasion has been similarly suggested, but its significance in OSCC patients with pt1 2N0 disease remains poorly understood. In this study we found that poor differentiation and depth of 4 mm or greater were univariate predictors of 5-year neck control, DFS, and DSS rates in OSCC patients with pt1 2N0 disease treated by surgery alone. After allowance for potential confounders, poor differentiation and tumor depth of 4 mm or greater retained their independent prognostic significance. Although several cutoff values for tumor depth have been reported (3 10), the optimal cutoff for predicting prognosis remains unclear. It is feasible that the best cutoff value for tumor depth may depend on different criteria used to select patients (e.g., T1 2 vs. T3 4). We have previously reported an optimal cutoff value of 10 mm
6 High-risk patients and pt1-2n0 OSCC d C.-T. LIAO et al. 289 for the entire group of OSCC patients (5 7), 35 mm for those with pt4n0 disease (4), and 12 mm for those with pn+ or extracapsular spread (9). A tumor depth of 5 mm or greater appeared to be the most appropriate cutoff for ND in buccal cancer patients with pt1 disease (3). Therefore treatment policies may vary according to the surgical oncologist s experience and preference. The combination of poor differentiation and tumor depth of 4 mm or greater led to the identification of four different prognostic groups. Although poor differentiation seems to be the most important negative predictor for 5-year neck control and survival rates, patients with both poor differentiation and tumor depth of less than 4 mm showed the best results in terms of outcomes, with 100% rates of control and survival at 5 years. Although this surprising result may be because of the small number of patients (n = 7) in this group, subjects in Group 4 (n = 12, poor differentiation and tumor depth $4 mm) showed the poorest outcome in terms of 5- year neck control, DFS, DSS, and OS rates. Patients in Group 4 account for only 3% of all pt1 2N0 patients in our study. It is worth noting that the number of patients in Groups 3 (n = 7) and 4 (n = 12) was so small that it is difficult to draw definite conclusions, especially on the potential role of postoperative RT. In Group 4, neck failure represents the major failure pattern, with an incidence of 42% within 2 years. In this patient group, postoperative RT may improve locoregional control. The results of the Radiation Therapy Oncology Group 9501 and European Organization for Research and Treatment of Cancer trials showed the usefulness of adjuvant concurrent chemoradiotherapy for improving locoregional control in advanced-stage highrisk patients (21, 22). Of note, the European Organization for Research and Treatment of Cancer trial enrolled T1 2N0 1 patients bearing pathologic risk factors. However, a comparative analysis of the two trials has shown that only patients with positive margins and/or positive lymph nodes with extracapsular spread would benefit from adjuvant concurrent chemoradiotherapy (23). We are currently investigating the potential usefulness of a therapeutic regimen consisting of two steps. Step 1 includes adjuvant RT alone. The second step consists of subsequent chemoradiotherapy or bioradiotherapy. Controls and survivals obtained in these therapeutic regimens will be compared with those of similar patients in our historical cohort. Several caveats of this study merit consideration. First, our data are limited to a survey of OSCC patients with pt1 2N0 selected from an endemic betel quid chewing area. Second, only a few high-risk patients (12 of 387 [3%]) were identified using tumor differentiation and tumor depth as the classification parameters. Finally, although univariate and multivariate analyses showed that poor differentiation was an independent risk factor for neck control and survival rates, patients in Group 3 (poor differentiation and depth <4 mm) showed the best survival and event-free rates. This unexpected result may be because of the small number of patients in this group (n = 7). Replication studies should be of sufficient sample size to address this issue. There are also several strengths of this report that distinguish it from previous studies. First, our investigation comprises the largest pt1 2N0 OSCC population described to date who received both wide excision of the tumor and ND. Second, all patients were uniformly assessed and treated according to our standardized protocol. Of note, our treatment policy resulted in similar survival rates in Groups 1, 2, and 3. In light of relatively poor control and survival rates observed in patients in Group 4, we conclude that such patients may benefit from more aggressive adjuvant therapies (radiation alone or chemoradiation). REFERENCES 1. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; National Comprehensive Cancer Network clinical practice guidelines in oncology, head and neck cancers, V.I Available from: URL: Accessed May 25, Liao CT, Wang HM, Ng SH, et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol 2006;42: Liao CT, Chang JT, Wang HM, et al. Survival in squamous cell carcinoma of the oral cavity: Differences between pt4n0 and other stage IVA categories. Cancer 2007;110: Liao CT, Wang HM, Chang JT, et al. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 2007;110: Liao CT, Chang JT, Wang HM, et al. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: How and when? Cancer 2008;112: Liao CT, Chang JT, Wang HM, et al. Analysis of risk factors predictive of local tumor control in oral cavity cancer. Ann Surg Oncol 2008;15: Liao CT, Huang SF, Chen IH, et al. Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann Surg Oncol 2009;16: Liao CT, Chang JT, Wang HM, et al. Pretreatment primary tumor SUVmax measured by FDG-PET and pathological tumor depth predict poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 2009;73: Liao CT, Wang HM, Chang JT, et al. The influence of pathological nodal status and SUVmax of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol 2010;77: Huang TY, Hsu LP, Wen YH, et al. Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol 2010;46: Arduino PG, Carrozzo M, Chiecchio A, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: A retrospective study of 334 cases. J Oral Maxillofac Surg 2008;66:
7 290 I. J. Radiation Oncology d Biology d Physics Volume 82, Number 1, Lo WL, Kao SY, Chi LY, et al. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: Factors affecting survival. J Oral Maxillofac Surg 2003;61: Rogers SN, Brown JS, Woolgar JA, et al. Survival following primary surgery for oral cancer. Oral Oncol 2009;45: Garzino-Demo P, Dell Acqua A, Dalmasso P, et al. Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma. J Craniomaxillofac Surg 2006;34: Kademani D, Bell RB, Bagheri S, et al. Prognostic factors in intraoral squamous cell carcinoma: The influence of histologic grade. J Oral Maxillofac Surg 2005;63: Hiratsuka H, Miyakawa A, Nakamori K, et al. Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 1997;80: Larsen SR, Johansen J, Sorensen JA, et al. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med 2009;38: Huang CH, Chu ST, Ger LP, et al. Clinicopathologic evaluation of prognostic factors for squamous cell carcinoma of the buccal mucosa. J Chin Med Assoc 2007;70: Iyer SG, Pradhan SA, Pai PS, et al. Surgical treatment outcomes of localized squamous carcinoma of buccal mucosa. Head Neck 2004;26: Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350: Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350: Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005; 27:
Surgical Outcome of T4a and Resected T4b Oral Cavity Cancer. BACKGROUND. The American Joint Committee on Cancer (AJCC) 2002 staging
337 Surgical Outcome of T4a and Resected T4b Oral Cavity Cancer Chun-Ta Liao, MD 1,2 Joseph Tung-Chieh Chang, MD, MHA 2,3 Hung-Ming Wang, MD 2,4 Shu-Hang Ng, MD 2,5 Chuen Hsueh, MD 2,6 Li-Yu Lee, MD 2,6
More informationPriority of Fibular Reconstruction in Patients with Oral Cavity Cancer Undergoing Segmental Mandibulectomy
Priority of Fibular Reconstruction in Patients with Oral Cavity Cancer Undergoing Segmental Mandibulectomy Chih-Hung Lin 1,2., Chung-Jan Kang 2,3., Chung-Kan Tsao 1,2, Christopher Glenn Wallace 1,2,3,
More informationSurvival impact of cervical metastasis in squamous cell carcinoma of hard palate
Vol. 116 No. 1 July 2013 Survival impact of cervical metastasis in squamous cell carcinoma of hard palate Quan Li, MD, a Di Wu, MD, b,c Wei-Wei Liu, MD, PhD, b,c Hao Li, MD, PhD, b,c Wei-Guo Liao, MD,
More informationDoes Buccal Cancer Have Worse Prognosis Than Other Oral Cavity Cancers?
The Laryngoscope VC 2014 The American Laryngological, Rhinological and Otological Society, Inc. Does Buccal Cancer Have Worse Prognosis Than Other Oral Cavity Cancers? P. Ryan Camilon, BA; William A. Stokes,
More informationORIGINAL ARTICLE. Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence
ORIGINAL ARTICLE Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence Michael D. Kernohan, FDSRCS, FRCS, MSc; Jonathan R. Clark, FRACS; Kan Gao, BEng; Ardalan Ebrahimi, FRACS;
More informationSQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY
ORIGINAL ARTICLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY Yi-Shing Leu 1,2,3 *, Yi-Fang Chang 4, Jehn-Chuan Lee 1, Chung-Ji Liu 2,5,6, Hung-Tao Hsiao 7, Yu-Jen Chen 8, Hong-Wen Chen 8,9,
More informationClinical and histological prognostic factors in locally advanced oral cavity cancers treated with primary surgery
European Annals of Otorhinolaryngology, Head and Neck diseases (2012) 129, 291 296 Available online at www.sciencedirect.com ORIGINAL ARTICLE Clinical and histological prognostic factors in locally advanced
More informationLymph node ratio as a prognostic factor in head and neck cancer patients
Chen et al. Radiation Oncology (2015) 10:181 DOI 10.1186/s13014-015-0490-9 RESEARCH Open Access Lymph node ratio as a prognostic factor in head and neck cancer patients Chien-Chih Chen 1*, Jin-Ching Lin
More informationAccepted 28 April 2005 Published online 13 September 2005 in Wiley InterScience ( DOI: /hed.
DEFINING RISK LEVELS IN LOCALLY ADVANCED HEAD AND NECK CANCERS: A COMPARATIVE ANALYSIS OF CONCURRENT POSTOPERATIVE RADIATION PLUS CHEMOTHERAPY TRIALS OF THE EORTC (#22931) AND RTOG (#9501) Jacques Bernier,
More informationLymph node density as an independent prognostic factor in node-positive patients with tonsillar cancer
ORIGINAL ARTICLE Lymph node density as an independent prognostic factor in node-positive patients with tonsillar cancer Jun-Ook Park, MD, PhD, 1 Young-Hoon Joo, MD, PhD, 2 Kwang-Jae Cho, MD, PhD, 2 Min-Sik
More informationAnalysis of the outcome of young age tongue squamous cell carcinoma
Jeon et al. Maxillofacial Plastic and Reconstructive Surgery (2017) 39:41 DOI 10.1186/s40902-017-0139-8 Maxillofacial Plastic and Reconstructive Surgery RESEARCH Open Access Analysis of the outcome of
More informationEFFICACY OF NECK DISSECTION FOR LOCOREGIONAL FAILURES VERSUS ISOLATED NODAL FAILURES IN NASOPHARYNGEAL CARCINOMA
ORIGINAL ARTICLE EFFICACY OF NECK DISSECTION FOR LOCOREGIONAL FAILURES VERSUS ISOLATED NODAL FAILURES IN NASOPHARYNGEAL CARCINOMA Raymond King Yin Tsang, FRCSEd, Joseph Chun Kit Chung, MRCSEd, Yiu Wing
More informationProtocol of Radiotherapy for Head and Neck Cancer
106 年 12 月修訂 Protocol of Radiotherapy for Head and Neck Cancer Indication of radiotherapy Indication of definitive radiotherapy with or without chemotherapy (1) Resectable, but medically unfit, or high
More informationCharacteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Characteristics and prognostic factors of synchronous multiple primary esophageal carcinoma: A report of 52 cases Mei Li & Zhi-xiong Lin Department of Radiation
More informationImproved outcomes in buccal squamous cell carcinoma
ORIGINAL ARTICLE Improved outcomes in buccal squamous cell carcinoma Chun Shu Lin, MD, 1 * Yee Min Jen, MD, PhD, 1 Woei Yau Kao, MD, PhD, 2 Ching Liang Ho, MD, 2 Ming Shen Dai, MD, PhD, 2 Chia Lin Shih,
More informationClinical Study Regional Failures after Selective Neck Dissection in Previously Untreated Squamous Cell Carcinoma of Oral Cavity
International Surgical Oncology, Article ID 205715, 8 pages http://dx.doi.org/10.1155/2014/205715 Clinical Study Regional Failures after Selective Neck Dissection in Previously Untreated Squamous Cell
More informationPositive Margins And Other Factors Associated With Survival In Early Stage Oral Cavity Squamous Cell Cancer: Prognostic Impact And Quality Measure
Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2015 Positive Margins And Other Factors Associated With Survival
More informationCorrelation of pretreatment surgical staging and PET SUV(max) with outcomes in NSCLC. Giancarlo Moscol, MD PGY-5 Hematology-Oncology UTSW
Correlation of pretreatment surgical staging and PET SUV(max) with outcomes in NSCLC Giancarlo Moscol, MD PGY-5 Hematology-Oncology UTSW BACKGROUND AJCC staging 1 gives valuable prognostic information,
More informationThe efficacy of postoperative radiation therapy in patients with carcinoma of the buccal mucosa and lower alveolus with positive surgical margins
Original Article The efficacy of postoperative radiation therapy in patients with carcinoma of the buccal mucosa and lower alveolus with positive surgical margins Badakh Dinesh K, Grover Amit H Dr. D.
More informationIrradiation for locoregionally recurrent, never-irradiated oral cavity cancers
ORIGINAL ARTICLE Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers Benjamin H. Lok, MD, 1 Christine Chin, BS, 1 Nadeem Riaz, MD, 1 Felix Ho, MD, 1 Man Hu, MD, 1 Julian C. Hong,
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationOral Cavity. 1. Introduction. 1.1 General Information and Aetiology. 1.2 Diagnosis and Treatment
Oral Cavity 1. Introduction 1.1 General Information and Aetiology The oral cavity extends from the lips to the palatoglossal folds and consists of the anterior two thirds of the tongue, floor of the mouth,
More informationPre- Versus Post-operative Radiotherapy
Postoperative Radiation and Chemoradiation: Indications and Optimization of Practice Dislosures Clinical trial support from Genentech Inc. Sue S. Yom, MD, PhD Associate Professor UCSF Radiation Oncology
More informationHsieh et al. Radiation Oncology (2016) 11:47 DOI /s
Hsieh et al. Radiation Oncology (2016) 11:47 DOI 10.1186/s13014-016-0617-7 RESEARCH Open Access Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall
More informationBone Metastases in Muscle-Invasive Bladder Cancer
Journal of the Egyptian Nat. Cancer Inst., Vol. 18, No. 3, September: 03-08, 006 AZZA N. TAHER, M.D.* and MAGDY H. KOTB, M.D.** The Departments of Radiation Oncology* and Nuclear Medicine**, National Cancer
More informationCancer of the Oral Cavity
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology Cancer of the Oral Cavity Ashok Shaha Principals of Management of Oral Cancer A)
More informationLymph node ratio as a prognostic factor in stage III colon cancer
Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com
More informationACR Appropriateness Criteria Adjuvant Therapy for Resected Squamous Cell Carcinoma of the Head and Neck EVIDENCE TABLE
1. Johnson JT, Barnes EL, Myers EN, Schramm VL, Jr., Borochovitz D, Sigler BA. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 1981; 107(1):75-79.. Snow GB, Annyas AA,
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationPoor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas
10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,
More informationClinical Significance of Preoperative Squamous Cell Carcinoma Antigen in Oral-Cavity Squamous Cell Carcinoma
The Laryngoscope VC 2011 The American Laryngological, Rhinological and Otological Society, Inc. Clinical Significance of Preoperative Squamous Cell Carcinoma Antigen in Oral-Cavity Squamous Cell Carcinoma
More informationSquamous cell carcinoma of buccal mucosa: a 40-year review,,
Available online at www.sciencedirect.com American Journal of Otolaryngology Head and Neck Medicine and Surgery 33 (2012) 673 677 www.elsevier.com/locate/amjoto Squamous cell carcinoma of buccal mucosa:
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationPrognostic value of pretreatment and recovery duration of cranial nerve palsy in nasopharyngeal carcinoma
Mo et al. Radiation Oncology 2012, 7:149 RESEARCH Open Access Prognostic value of pretreatment and recovery duration of cranial nerve palsy in nasopharyngeal carcinoma Hao-Yuan Mo 1,2, Rui Sun 1,2, Jian
More informationSelf-Assessment Module 2016 Annual Refresher Course
LS16031305 The Management of s With r. Lin Learning Objectives: 1. To understand the changing demographics of oropharynx cancer, and the impact of human papillomavirus on overall survival and the patterns
More informationSupplementary Information
Supplementary Information Prognostic Impact of Signet Ring Cell Type in Node Negative Gastric Cancer Pengfei Kong1,4,Ruiyan Wu1,Chenlu Yang1,3,Jianjun Liu1,2,Shangxiang Chen1,2, Xuechao Liu1,2, Minting
More informationHow to Manage a Case of Stage-I Oropharyngeal Cancer with Very Close Cutting End Post-Operatively?
How to Manage a Case of Stage-I Oropharyngeal Cancer with Very Close Cutting End Post-Operatively? Case Number: RT2008-07(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor
More informationA phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008
A phase II study of weekly paclitaxel and cisplatin followed by radical hysterectomy in stages IB2 and IIA2 cervical cancer AGOG14-001/TGOG1008 NCT02432365 Chyong-Huey Lai, MD On behalf of Principal investigator
More information(loco-regional disease)
(loco-regional disease) (oral cavity) (circumvillae papillae) (subsite) A (upper & lower lips) B (buccal membrane) C (mouth floor) D (upper & lower gingiva) E (hard palate) F (tongue -- anterior 2/3 rds
More informationPatient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival
MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS
More informationLip. 1. Introduction. 1.1 General Information and Aetiology
Lip 1. Introduction 1.1 General Information and Aetiology Lips are the external part of the mouth. They are bounded externally by facial skin. On the oral cavity side, they are continuous with buccal mucosa
More informationHPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view. Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium
HPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium DISCLOSURE OF INTEREST Nothing to declare HEAD AND NECK CANCER -HPV
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationOral cancer: Prognosis & Treatment. Dr. Hani Al Sheikh Radhi
Oral cancer: Prognosis & Treatment Dr. Hani Al Sheikh Radhi Prognostic factors in Oral caner TNM staging T stage N stage M stage Site Histological Factors Vascular & Perineural Invasion Surgical Margins
More informationPrognostic factors in squamous cell anal cancers
Prognostic factors in squamous cell anal cancers Zainul Abedin Kapacee Year 4-5 Intercalating Medical Student, University of Manchester Dr. Shabbir Susnerwala, Mr. Nigel Scott Dr. Falalu Danwata, Dr. Marcus
More informationEvaluation of AJCC, UICC, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma
Evaluation of AJCC, UICC, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma Karia, et al Methods Details of data collectionfeatures of primary tumors including anatomic
More informationOnly Estrogen receptor positive is not enough to predict the prognosis of breast cancer
Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors
More informationComparative evaluation of oral cancer staging using PET-CT vs. CECT
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 5 (2015) pp. 1168-1175 http://www.ijcmas.com Original Research Article Comparative evaluation of oral
More informationJMSCR Vol 05 Issue 05 Page May 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i5.92 Clinicopathological Profile & Correlation
More informationDesmoplastic Melanoma: Surgical Management and Adjuvant Therapy
Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Dale Han, MD Assistant Professor Department of Surgery Section of Surgical Oncology No disclosures Background Desmoplastic melanoma (DM)
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationTrehan S et al: Depth of invasion and tumour size on risk of neck node metastasis
Original Article The effect of depth of invasion and tumour size on risk of neck node metastasis in squamous cell carcinoma of oral cavity: retrospective analysis Shyam S Trehan*, Kartik Patel*, HK Shukla**,
More informationFan et al. Radiation Oncology (2017) 12:184 DOI /s
Fan et al. Radiation Oncology (2017) 12:184 DOI 10.1186/s13014-017-0910-0 RESEARCH Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three
More informationMedicine OBSERVATIONAL STUDY
Medicine OBSERVATIONAL STUDY An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma Chun-Ta Liao, MD, Shu-Jen
More informationAdjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support
Adjuvant Therapy in Locally Advanced Head and Neck Cancer Ezra EW Cohen University of Chicago Financial Support This program is made possible by an educational grant from Eli Lilly Oncology, who had no
More informationEVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013
EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationClinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital
Clinical Discussion Dr Pankaj Chaturvedi Professor and Surgeon Tata Memorial Hospital chaturvedi.pankaj@gmail.com 47/M/smoker Hopkins : Transglottic lesion No cartilage infiltration but sclerosis Left
More informationIndeterminate Pulmonary Nodules in Patients with Colorectal Cancer
Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Jai Sule 1, Kah Wai Cheong 2, Stella Bee 2, Bettina Lieske 2,3 1 Dept of Cardiothoracic and Vascular Surgery, University Surgical Cluster,
More informationSurgical Margins in Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
Surgical Margins in Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma Consensus update and recommendations, 2018 Head and Neck Steering Committee P. Gorphe *, F. Nguyen, Y. Tao, P. Blanchard,
More informationTreatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy
Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo
More informationClinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment
Page 1 of 7 Clinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment X Peng 1, SF Chen 2, C Du 2 *, P Yang 2, SX Liang 2, G Zhang 3, X Dong 4 *,
More informationSquamous Cell Carcinoma of the Oral Cavity: Radio therapeutic Considerations
Squamous Cell Carcinoma of the Oral Cavity: Radio therapeutic Considerations Troy G. Scroggins Jr. MD Chairman, Department of Radiation Oncology Ochsner Health Systems 1 Association of Postoperative Radiotherapy
More informationPostoperative Radiotherapy in Salivary Gland Carcinoma: A Single Institution Experience
Original Article Postoperative Radiotherapy in Salivary Gland Carcinoma: A Single Institution Experience Öztun Temelli, Ersoy Kekilli 2, Ahmet Kızılay Department of Radiation Oncology, 2 Department of
More informationBone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When PET Scans Findings Are Equivocal: A Case Report
Bone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When Scans Findings Are Equivocal: A Case Report Yuk-Wah Tsang 1, Jyh-Gang Leu 2, Yen-Kung Chen 3, Kwan-Hwa Chi 1,4
More informationElective neck treatment in clinically node-negative paranasal sinus carcinomas: impact on treatment outcome
Original Article Radiat Oncol J 218;36(4):34-316 https://doi.org/1.3857/roj.218.416 pissn 2234-19 eissn 2234-3156 Elective neck treatment in clinically node-negative paranasal sinus carcinomas: impact
More informationThe current treatment for oral cancer is wide
ORIGINAL ARTICLE RARE INVOLVEMENT OF SUBMANDIBULAR GLAND BY ORAL SQUAMOUS CELL CARCINOMA Tseng-Cheng Chen, MD, 1 Wu-Chia Lo, MD, 1 Jenq-Yuh Ko, MD, PhD, 1 Pei-Jen Lou, MD, PhD, 1 Tsung-Lin Yang, MD, 1,2
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationLONG-TERM SURGICAL OUTCOMES OF 1018 PATIENTS WITH EARLY STAGE NSCLC IN ACOSOG Z0030 (ALLIANCE) TRIAL
LONG-TERM SURGICAL OUTCOMES OF 1018 PATIENTS WITH EARLY STAGE NSCLC IN ACOSOG Z0030 (ALLIANCE) TRIAL Stacey Su, MD; Walter J. Scott, MD; Mark S. Allen, MD; Gail E. Darling, MD; Paul A. Decker, MS; Robert
More informationSurgical outcomes in cases of postoperative recurrence of primary oral cancer that required reconstruction
Acta Med. Nagasaki 60: 119 124 MS#AMN 07187 Surgical outcomes in cases of postoperative recurrence of primary oral cancer that required reconstruction Shinya Ji n n o u c h i, MD 1, Kenichi Ka n e ko,
More informationARTICLE IN PRESS. doi: /j.ijrobp METAPLASTIC CARCINOMA OF THE BREAST: A RETROSPECTIVE REVIEW
doi:10.1016/j.ijrobp.2005.08.024 Int. J. Radiation Oncology Biol. Phys., Vol. xx, No. x, pp. xxx, 2005 Copyright 2005 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/05/$ see front matter
More informationLaryngeal Preservation Using Radiation Therapy. Chemotherapy and Organ Preservation
1 Laryngeal Preservation Using Radiation Therapy 1903: Schepegrell was the first to perform radiation therapy for the treatment of laryngeal cancer Conventional external beam radiation produced disappointing
More informationRepeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best Candidates
Ann Surg Oncol (2012) 19:3771 3776 DOI 10.1245/s10434-012-2404-5 ORIGINAL ARTICLE BREAST ONCOLOGY Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the
More informationOral cavity cancer Post-operative treatment
Oral cavity cancer Post-operative treatment Dr. Christos CHRISTOPOULOS Radiation Oncologist Centre Hospitalier Universitaire (C.H.U.) de Limoges, France Important issues RT -techniques Patient selection
More informationCountry Presentations of FNCA FY2007 Workshop on Radiation Oncology
Country Presentations of FNCA FY2007 Workshop on Radiation Oncology Annex 3 Country presentations on CERVIX-III -China: Total Patients: 18, 8 alive: 1 with metastasis lung, another one metastasis to liver;
More informationTranslating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy
American Academy of Dermatology 2018 Annual Meeting San Diego, CA, February 17, 2018 Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy Christopher Bichakjian,
More informationOutcome of Treatment with Total Main Tumor Resection and Supraomohyoid Neck Dissection in Oral Squamous Cell Carcinoma
ORIGINAL ARTICLE Outcome of Treatment with Total Main Tumor Resection and Supraomohyoid Neck Dissection in Oral Squamous Cell Carcinoma Gwo-An Liaw, 1 Ching-Yu Yen, 2,3 Wei-Fan Chiang, 2 Chin-Hai Lee,
More informationKatsuro Sato. Department of Speech, Language and Hearing Sciences, Niigata University of Health and Welfare, Niigata, Japan
Report Niigata Journal of Health and Welfare Vol. 12, No. 1 Retrospective analysis of head and neck cancer cases from the database of the Niigata Prefecture Head and Neck Malignant Tumor Registration Committee
More informationTumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma
ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI
More informationLong term survival study of de-novo metastatic breast cancers with or without primary tumor resection
Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Dr. Michael Co Division of Breast Surgery Queen Mary Hospital The University of Hong Kong Conflicts
More informationIs an Elective Neck Dissection Necessary for All Cases of N0 Oral Squamous Cell Carcinoma?
Tokai J Exp Clin Med., Vol. 41, No. 3, pp. 112-117, 2016 Is an Elective Neck Dissection Necessary for All Cases of N0 Oral Squamous Cell Carcinoma? Elective Neck Dissection may be Performed for Tongue
More informationClinical analysis of 29 cases of nasal mucosal malignant melanoma
1166 Clinical analysis of 29 cases of nasal mucosal malignant melanoma HUANXIN YU and GANG LIU Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China
More informationPMRT for N1 breast cancer :CONS. Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center
PMRT for N1 breast cancer :CONS Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center DBCG 82 b & c Overgaard et al Radiot Oncol 2007 1152 pln(+), 8 or more nodes removed Systemic
More informationEffect of number and ratio of positive lymph nodes in hypopharyngeal cancer
ORIGINAL ARTICLE Effect of number and ratio of positive lymph nodes in hypopharyngeal cancer Yong-hong Hua, MD, PhD, Qiao-ying Hu, MD, * Yong-feng Piao, MD, Qiu Tang, MD, PhD, Zhen-fu Fu, MD Head and Neck
More informationRadiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy. Julia White MD Professor, Radiation Oncology
Radiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy Julia White MD Professor, Radiation Oncology Agenda Efficacy of radiotherapy in the management of breast cancer in the Adjuvant
More informationThe clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population
Zhang et al. BMC Cancer (2019) 19:22 https://doi.org/10.1186/s12885-018-5147-2 RESEARCH ARTICLE Open Access The clinicopathological features and treatment modalities associated with survival of neuroendocrine
More informationRadical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors
ORIGINAL ARTICLE Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors Chen-Hsun Ho, 1,2 Chao-Yuan Huang, 1 Wei-Chou Lin, 3 Shih-Chieh Chueh, 1 Yeong-Shiau
More informationFINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma
Case Scenario 1 HNP: A 70 year old white male presents with dysphagia. The patient is a current smoker, current user of alcohol and is HPV positive. A CT of the Neck showed mass in the left pyriform sinus.
More informationA variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study
ORIGINAL ARTICLE A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study Joon-Hyop Lee, MD, Yoo Seung Chung, MD, PhD,* Young Don Lee, MD, PhD
More informationORIGINAL ARTICLE. Clinical Node-Negative Thick Melanoma
ORIGINAL ARTICLE Clinical Node-Negative Thick Melanoma George I. Salti, MD; Ashwin Kansagra, MD; Michael A. Warso, MD; Salve G. Ronan, MD ; Tapas K. Das Gupta, MD, PhD, DSc Background: Patients with T4
More informationGhadjar et al. Radiation Oncology (2015) 10:21 DOI /s y
Ghadjar et al. Radiation Oncology (2015) 10:21 DOI 10.1186/s13014-014-0319-y RESEARCH Open Access Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary
More informationWHAT DOES PET IMAGING ADD TO CONVENTIONAL STAGING OF HEAD AND NECK CANCER PATIENTS?
doi:10.1016/j.ijrobp.2006.12.044 Int. J. Radiation Oncology Biol. Phys., Vol. 68, No. 2, pp. 383 387, 2007 Copyright 2007 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/07/$ see front
More informationTriple-Modality Treatment in Patients With Advanced Stage Tonsil Cancer
Triple-Modality Treatment in Patients With Advanced Stage Tonsil Cancer Dylan F. Roden, MD, MPH 1,2 ; David Schreiber, MD 2,3 ; and Babak Givi, MD 1,2 BACKGROUND: Concurrent chemoradiation (CCRT) and upfront
More informationLocoregional recurrences are the most frequent
ORIGINAL ARTICLE SECOND SALVAGE SURGERY FOR RE-RECURRENT ORAL CAVITY AND OROPHARYNX CARCINOMA Ivan Marcelo Gonçalves Agra, MD, PhD, 1 João Gonçalves Filho, MD, PhD, 2 Everton Pontes Martins, MD, PhD, 2
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationClinical Study Primary Surgical Therapy for Locally Limited Oral Tongue Cancer
BioMed Research International, Article ID 738716, 6 pages http://dx.doi.org/10.1155/2014/738716 Clinical Study Primary Surgical Therapy for Locally Limited Oral Tongue Cancer Konstantinos Mantsopoulos,
More informationLower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance
Original Article Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Dedrick Kok Hong Chan 1,2, Ker-Kan Tan 1,2 1 Division of Colorectal Surgery, University
More informationImplications of ACOSOG Z11 for Clinical Practice: Surgical Perspective
:$;7)#*8'-87*4BCD'E7)F'31$4.$&'G$H'E7)F&'GE'>??ID >?,"'@4,$)4*,#74*8'!74/)$++'74',"$'A.,.)$'7%'()$*+,'!*42$)!7)74*67&'!3 6 August 2011 Implications of ACOSOG Z11 for Clinical
More informationClinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy
Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy Mitsui Memorial Hospital Department of Breast and Endocine surgery Daisuke Ota No financial support
More informationWhen to Integrate Surgery for Metatstatic Urothelial Cancers
When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male
More information